Patient Preferences: Understanding Risk-Benefit Trade-Offs of Genomic Testing in Chemotherapy Decisions for Breast Cancer Patients

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.724
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Understanding and Utilizing Patient Preferences in Cancer Treatment Decisions

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Quantifying Preferences in Drug Benefit‐Risk Decisions

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Who Gets Genomic Testing for Breast Cancer Recurrence Risk?

Public Health Genomics
EnvironmentalPublic HealthGeneticsOccupational Health
2013English

Trade-Offs in Make-Buy Decisions

Journal of Purchasing and Supply Management
MarketingManagementStrategy
2011English

Incorporating Value Trade-Offs Into Community-Based Environmental Risk Decisions

Environmental Values
PhilosophyEnvironmental Science
2002English

Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Lung Cancer Patients Vary in Their Preferences for Chemotherapy

BMJ
1998English

Molecular Genomic Testing for Breast Cancer: Utility for Surgeons

Annals of Surgical Oncology
OncologySurgery
2017English

Preferences for Multigene Panel Testing for Hereditary Breast Cancer Risk Among Ethnically Diverse BRCA-uninformative Families

Journal of Community Genetics
EnvironmentalPublic HealthGeneticsEpidemiologyOccupational Health
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy